Can volumetric ADC measurement help predict response to Y90 radioembolization in HCC?

Verfasser / Beitragende:
[Michael Vouche, Riad Salem, Robert Lewandowski, Frank Miller]
Ort, Verlag, Jahr:
2015
Enthalten in:
Abdominal Imaging, 40/6(2015-08-01), 1471-1480
Format:
Artikel (online)
ID: 605492433
LEADER caa a22 4500
001 605492433
003 CHVBK
005 20210128100515.0
007 cr unu---uuuuu
008 210128e20150801xx s 000 0 eng
024 7 0 |a 10.1007/s00261-014-0295-6  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00261-014-0295-6 
245 0 0 |a Can volumetric ADC measurement help predict response to Y90 radioembolization in HCC?  |h [Elektronische Daten]  |c [Michael Vouche, Riad Salem, Robert Lewandowski, Frank Miller] 
520 3 |a Aim: To compare changes in RECIST, anatomical volume, mRECIST, and volumetric diffusion-weighted Imaging parameters (3D apparent diffusion coefficient (ADC) measurements), with pathological analysis of hepatocellular carcinoma (HCC) treated by 90Yttrium radioembolization (Y90). Methods: 21 patients were treated by Y90 as a sole treatment modality for solitary, >2cm HCC that underwent liver transplantation. MRI at baseline, 1 and 3months post-Y90, and tumor pathological findings on explants were reviewed in all patients. Results: Compared to baseline (RECIST/volume: 3.6cm/17.7cm3), RECIST and volume were not modified after Y90 (1month, p=0.28/0.09 RECIST/tumor volume; 3months, p=0.28/0.54). In contrast, mRECIST (3.3-1.4cm, p<0.001), mean ADC (0.185-1.093mm2/s×10−3, p=0.04), and ADC standard deviation (STD) (0.041-0.201mm2/s×10−3, p=0.0496) changed as earlier as 1month post-Y90. ADC STD % change was higher in ADC responding lesions than non-responding lesions at 1month (p=0.002) and 3months (p=0.008). All lesions exhibited necrosis on pathological analysis (11 partially viable, 10 complete pathological necrosis (CPN)) but no imaging criterion was able to predict CPN. mRECIST (±ADC) at 1 (κ±ADC=0.08/0.06) or 3months (κ=−0.06/−0.06) were poor predictors of pathological response. Conclusion: As soon as 1month post-treatment, mRECIST and volumetric ADC performed better than traditional size RECIST or volumetric parameters in detecting imaging response to Y90; however, CPN cannot be predicted by any criteria. Improvements in methodologies to assess response and identification of better surrogates are awaited. 
540 |a Springer Science+Business Media New York, 2014 
690 7 |a Hepatocellular carcinoma  |2 nationallicence 
690 7 |a Radioembolization  |2 nationallicence 
690 7 |a Yttrium-90  |2 nationallicence 
690 7 |a Response assessment  |2 nationallicence 
690 7 |a ADC  |2 nationallicence 
690 7 |a ADC : Apparent diffusion coefficient  |2 nationallicence 
690 7 |a cTACE : Conventional transarterial chemoembolization  |2 nationallicence 
690 7 |a CPN : Complete pathological necrosis  |2 nationallicence 
690 7 |a DWI : Diffusion-weighted imaging  |2 nationallicence 
690 7 |a GRE : Gradient echo  |2 nationallicence 
690 7 |a (m)RECIST : (Modified) response criteria in solid tumors  |2 nationallicence 
690 7 |a MRI : Magnetic resonance imaging  |2 nationallicence 
690 7 |a IQR : Interquartile range  |2 nationallicence 
690 7 |a 99Tc-MAA : 99Technetium-macroaggregated albumin  |2 nationallicence 
690 7 |a STD : Standard deviation  |2 nationallicence 
690 7 |a Y90 : 90Yttrium radioembolization  |2 nationallicence 
700 1 |a Vouche  |D Michael  |u Section of Interventional Radiology and Division of Interventional Oncology, Department of Radiology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA  |4 aut 
700 1 |a Salem  |D Riad  |u Section of Interventional Radiology and Division of Interventional Oncology, Department of Radiology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA  |4 aut 
700 1 |a Lewandowski  |D Robert  |u Section of Interventional Radiology and Division of Interventional Oncology, Department of Radiology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA  |4 aut 
700 1 |a Miller  |D Frank  |u Department of Radiology, Feinberg School of Medicine, Northwestern Memorial Hospital, Northwestern University, 676 North Saint Clair Street Suite 800, 60611, Chicago, IL, USA  |4 aut 
773 0 |t Abdominal Imaging  |d Springer US; http://www.springer-ny.com  |g 40/6(2015-08-01), 1471-1480  |x 0942-8925  |q 40:6<1471  |1 2015  |2 40  |o 261 
856 4 0 |u https://doi.org/10.1007/s00261-014-0295-6  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00261-014-0295-6  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Vouche  |D Michael  |u Section of Interventional Radiology and Division of Interventional Oncology, Department of Radiology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Salem  |D Riad  |u Section of Interventional Radiology and Division of Interventional Oncology, Department of Radiology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Lewandowski  |D Robert  |u Section of Interventional Radiology and Division of Interventional Oncology, Department of Radiology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Miller  |D Frank  |u Department of Radiology, Feinberg School of Medicine, Northwestern Memorial Hospital, Northwestern University, 676 North Saint Clair Street Suite 800, 60611, Chicago, IL, USA  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Abdominal Imaging  |d Springer US; http://www.springer-ny.com  |g 40/6(2015-08-01), 1471-1480  |x 0942-8925  |q 40:6<1471  |1 2015  |2 40  |o 261